Clinical Trials on Infection Staphylococcal in Belgium

Total 1519 results

GlaxoSmithKline
Bill and Melinda Gates Foundation; Wellcome Trust; Biomedical Advanced Research... and other collaborators

Recruiting

A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever

Salmonella Infections

Belgium, Malawi
Institute of Tropical Medicine, Belgium
Novosanis NV

Completed

Evaluation of the Use of the Colli-Pee Device to Collect First-void Urine for Molecular Detection of STIs (Colli-Pee)

Sexually Transmitted Diseases, Bacterial

Belgium
University Hospital, Ghent

Completed

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

COVID-19 | Critical Illness | Deep Vein Thrombosis | Anticoagulants and Bleeding Disorders

Belgium
MEDA Pharma GmbH & Co. KG
ORION Sante

Completed

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

Warts

Belgium, France
Clinique Saint Pierre Ottignies

Unknown

Predictive Models for Intensive Care Admission and Death of COVID-19

Pneumonia, Viral | Inflammatory Response | COVID19

Belgium
Universitaire Ziekenhuizen KU Leuven
Hospital Clinic of Barcelona; Universitair Ziekenhuis Brussel; Max Planck Research... and other collaborators

Recruiting

ANalyzing Olfactory Dysfunction Mechanisms In COVID-19 (ANOSMIC-19)

SARS-CoV-2

Belgium
Hasselt University
Jessa Hospital; University of Warwick; Claude Bernard University; AIT Austrian... and other collaborators

Completed

Fast Assay for Pathogen Identification - Quasi-Experimental Intervention Study (FAPIC-QE)

Sepsis | Septic Shock | Bacteremia

Belgium
Hasselt University
Jessa Hospital; University of Warwick; University of Zagreb; Claude Bernard University and other collaborators

Completed

Fast Assay for Pathogen Identification and Characterization (FAPIC)

Sepsis | Septic Shock | Bacteremia

Belgium
University Hospital, Gasthuisberg

Unknown

Outcome After Treatment of Pulmonary Aspergilloma

Pulmonary Fungal Diseases

Belgium
National Multiple Sclerosis Center
Universitaire Ziekenhuizen KU Leuven

Withdrawn

Bladder Lavage as Decontamination Method for Asymptomatic Bacteriuria With Uropathogens in Catheterized Patients

Catheter Related Infections

Belgium
McNeil AB

Completed

Efficacy and Safety of Sinutab on Subjects in the Setting of a Common Cold

Headache | Nasal Congestion | Common Cold

Belgium
Pierre Van Damme
Bill and Melinda Gates Foundation; Centers for Disease Control and Prevention; PA... and other collaborators

Completed

A Phase 2 Study to Evaluate the Safety and Immunogenicity of Two Oral Poliovirus Vaccine Candidates

Poliomyelitis

Belgium
Maastricht University Medical Center
CyTuVax

Completed

Hepatitis B Vaccine for Non-responders

Hepatitis B

Belgium, Netherlands
GlaxoSmithKline

Completed

Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™

Hepatitis B | Hepatitis A

Belgium, Czechia
Bharat Biotech International Limited

Active, not recruiting

Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers (Nasal154PH3)

COVID-19 Respiratory Infection

India
Erasme University Hospital

Unknown

Corticosteroids in Alcoholic Hepatitis

Alcoholic Hepatitis

Belgium
GlaxoSmithKline

Completed

Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)

Infections, Papillomavirus

Belgium
University Hospital, Ghent

Completed

Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults (IPV-004)

Poliomyelitis

Belgium
CureVac

Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults

Rabies

Belgium, Germany
Universitaire Ziekenhuizen KU Leuven

Completed

Evaluation of Exhaled Breath Condensate in the Diagnosis of Invasive Pulmonary Aspergillosis

Invasive Pulmonary Aspergillosis

Belgium
Novartis Vaccines

Completed

Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects

Influenza | Seasonal Influenza | Human Influenza | Influenza Due to Unspecified Influenza Virus

Belgium
Erasme University Hospital

Completed

N-Acetylcysteine in Severe Acute Alcoholic Hepatitis

Alcoholic Hepatitis

Belgium
GlaxoSmithKline

Completed

Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination

Hepatitis B | Hepatitis A

Belgium, Czechia
University Hospital, Ghent
UCB Pharma SA

Completed

Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis (SCINTRA)

Rheumatoid Arthritis | Axial and Peripheral Spondyloarthritis

Belgium
Cliniques universitaires Saint-Luc- Université...
BioMérieux

Completed

Trial Measuring the Clinical Impact of the FilmArray® Pneumonia Panel in Critically Ill (FA-PNEU)

Pneumonia

Belgium
University Hospital, Ghent

Completed

Pharmacokinetic Evaluation of Moxifloxacin IV to Enteral Switch Therapy in Intensive Care Patients

Pneumonia

Belgium
Vésale Hospital
Janssen-Cilag Ltd.

Completed

Onychomycosis: Diagnosis and Prevalence in Diabetic Neuropathic Patients

Prevalence of Onychomycosis | Diabetic Neuropathic Patients | Diagnostic of Onychomycosis | Patients Clinically Suspected of Onychomycosis | Reliability of the Diagnosis of Onychomycosis

Belgium
Erasme University Hospital

Completed

Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Disease Patients

Influenza | Rejection | Decreased Immunologic Activity [PE]

Belgium
Abbott Biologicals
Quintiles, Inc.

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 Season

Influenza

Belgium, Germany
Solvay Biologicals

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season.

Influenza

Belgium, Germany
Erasme University Hospital

Completed

Effect of the TEGO Connector in Preventing Tunneled Cuffed Hemodialysis Catheters From Dysfunction and/or Bacteremia

Other Complication of Vascular Dialysis Catheter

Belgium
University Hospital, Ghent

Recruiting

Sequential Analysis Before and After Treatment Initiation to Unravel the Role of Naturally Occurring Extracellular Vesicles in HIV Infection (Saturne-HIV)

Hiv

Belgium
Ology Bioservices

Completed

Adult Safety Study of 2009/2010 Seasonal Influenza Vaccine

Influenza

Austria, Belgium
Abbott Biologicals
Quintiles, Inc.

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2010/2011 Season

Influenza

Belgium, Germany
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).

Hepatitis B

Denmark, Belgium
Janssen Sciences Ireland UC

Completed

Relative Bioavailability and Food Effect for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination

Healthy

Belgium
KU Leuven

Completed

Predictive Factors and Outcome in Medical Thoracoscopy

Pleuritis

Belgium
Erasme University Hospital
University of Liege; Universitair Ziekenhuis Brussel; University Hospital, Lille and other collaborators

Completed

The Bacteriuria in Renal Transplantation (BiRT) Study: A Trial Comparing Antibiotics Versus no Treatment in the Prevention of Symptomatic Urinary Tract Infection in Kidney Transplant Recipients With Asymptomatic Bacteriuria (BiRT)

Bacteriuria | Urinary Tract Infections | Kidney Transplantation | Asymptomatic Bacteriuria

Belgium, France
University Hospital, Ghent
Imec; Research Foundation Flanders

Not yet recruiting

Validation of Betalactam ML Prediction Models - TDMAide (TDMAide)

Infections

Belgium
GlaxoSmithKline

Completed

Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose

AIDS

Belgium
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults

Respiratory Syncytial Virus (RSV)

Belgium
Tibotec Pharmaceuticals, Ireland

Completed

A Study of Drug-drug Interaction Between Ritonavir and TMC435350 in Healthy Volunteers

Healthy

Belgium
ViiV Healthcare
Pfizer

Completed

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Healthy

Belgium
Janssen R&D Ireland

Completed

A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of Digoxin

Healthy

Belgium
ViiV Healthcare
Pfizer

Completed

Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects

Healthy

Belgium
Institute of Tropical Medicine, Belgium

Withdrawn

Use of Malaria Rapid Diagnostic Tests as a Decision Aid for the Management of Fever by International Travelers (JOKA-I)

Fever | Malaria

Belgium
GlaxoSmithKline

Completed

Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population

Infections, Streptococcal

Belgium, Sweden, Finland
Solvay Pharmaceuticals

Completed

Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in Europe

Healthy Volunteers

Belgium, Germany
University Hospital, Ghent
CEVAC Core Lab, University Ghent; Max Planck Institute for Infection Biology... and other collaborators

Completed

Study of Biomarkers of Immune Activation Associated With Symptoms and Immune Responses After Influenza Vaccination in Adults

Prevention of Influenza

Belgium
GlaxoSmithKline

Completed

A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays

Immunologic Tests

Belgium

3

Subscribe